Show simple item record

dc.contributor.authorTighe, Dennis A.
dc.contributor.authorAurigemma, Gerard P.
dc.date2022-08-11T08:08:02.000
dc.date.accessioned2022-08-23T15:40:30Z
dc.date.available2022-08-23T15:40:30Z
dc.date.issued2016-10-10
dc.date.submitted2018-05-02
dc.identifier.citation<p>Circ Cardiovasc Imaging. 2016 Oct;9(10). pii: e005683. 10.1161/CIRCIMAGING.116.005683. <a href="https://doi.org/10.1161/CIRCIMAGING.116.005683">Link to article on publisher's site</a></p>
dc.identifier.issn1941-9651 (Linking)
dc.identifier.doi10.1161/CIRCIMAGING.116.005683
dc.identifier.pmid27894073
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26414
dc.description.abstractCalcific degenerative aortic valve stenosis (AS) is the most common acquired form of heart valve disease that afflicts the elderly population1 and usually comes to attention when an echocardiogram is ordered to evaluate a systolic murmur in an older subject. As is evident to anyone practicing cardiology these days, the advent of transcatheter aortic valve replacement has focused much attention on the evaluation and optimal treatment of patients with AS. AS often has a long latency period in which symptoms are absent, and, importantly, sudden unexpected cardiac death is rare.2,3 With symptom onset, survival is markedly reduced without intervention.4–6 For symptomatic patients with severe AS and normal flow-high gradient characteristics and normal left ventricular ejection fraction (LVEF) (stage D1), aortic valve replacement (AVR) is a class 1 indication. Similarly, for asymptomatic patients with severe AS and LVEF less than fifty percent not because of another cause (stage C2), AVR also is indicated.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=27894073&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1161/CIRCIMAGING.116.005683
dc.subjectEditorials
dc.subjectaortic valve stenosis
dc.subjectechocardiography
dc.subjectheart valve disease
dc.subjecthemodynamics
dc.subjectleft atrium
dc.subjectsystolic murmur
dc.subjectCardiology
dc.subjectCardiovascular Diseases
dc.subjectGeriatrics
dc.subjectPathological Conditions, Signs and Symptoms
dc.subjectSurgical Procedures, Operative
dc.subjectTherapeutics
dc.titleC'est LAVi: What Left Atrial Dilatation Tells Us About Diastolic Function in Aortic Stenosis
dc.typeEditorial
dc.source.journaltitleCirculation. Cardiovascular imaging
dc.source.volume9
dc.source.issue10
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cardio_pp/96
dc.identifier.contextkey12057196
html.description.abstract<p>Calcific degenerative aortic valve stenosis (AS) is the most common acquired form of heart valve disease that afflicts the elderly population<sup><a href="http://circimaging.ahajournals.org/content/9/10/e005683.long#ref-1" id="x-x-x-x-xref-ref-1-1">1</a></sup> and usually comes to attention when an echocardiogram is ordered to evaluate a systolic murmur in an older subject. As is evident to anyone practicing cardiology these days, the advent of transcatheter aortic valve replacement has focused much attention on the evaluation and optimal treatment of patients with AS. AS often has a long latency period in which symptoms are absent, and, importantly, sudden unexpected cardiac death is rare.<sup><a href="http://circimaging.ahajournals.org/content/9/10/e005683.long#ref-2" id="x-x-x-x-xref-ref-2-1">2</a>,<a href="http://circimaging.ahajournals.org/content/9/10/e005683.long#ref-3" id="x-x-x-x-xref-ref-3-1">3</a></sup> With symptom onset, survival is markedly reduced without intervention.<sup><a href="http://circimaging.ahajournals.org/content/9/10/e005683.long#ref-4" id="x-x-x-x-xref-ref-4-1">4</a><a href="http://circimaging.ahajournals.org/content/9/10/e005683.long#ref-5" id="x-x-x-x-xref-ref-5-1">–</a><a href="http://circimaging.ahajournals.org/content/9/10/e005683.long#ref-6" id="x-x-x-x-xref-ref-6-1">6</a></sup> For symptomatic patients with severe AS and normal flow-high gradient characteristics and normal left ventricular ejection fraction (LVEF) (stage D1), aortic valve replacement (AVR) is a class 1 indication. Similarly, for asymptomatic patients with severe AS and LVEF less than fifty percent not because of another cause (stage C2), AVR also is indicated.</p>
dc.identifier.submissionpathcardio_pp/96
dc.contributor.departmentDivision of Cardiovascular Medicine, Department of Medicine


This item appears in the following Collection(s)

Show simple item record